Oral manifestations in mild-to-moderate cases of COVID-19 viral infection in the adult population

被引:39
|
作者
Abubakr, Nermeen [1 ]
Salem, Zeinab Amin [1 ]
Kamel, Amany Hany Mohamed [1 ]
机构
[1] Cairo Univ, Fac Dent, Dept Oral Biol, Giza, Egypt
关键词
xerostomia; oral hygiene; halitosis; coronavirus; COVID-19; CLINICAL CHARACTERISTICS;
D O I
10.17219/dmp/130814
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background. Coronavirus disease 2019 (COVID-19) is a serious worldwide threat presented by a broad range of symptoms, from mild flu to severe pneumonia. A rising number of atypical infections have been reported. Thus, scientists and clinicians are doing hard work to unravel scientific knowledge about this novel pandemic. Objectives. The aim of the present work was to highlight the oral manifestations which could be observed in mild-to-moderate cases of COVID-19. Material and methods. A questionnaire survey was performed on 665 Egyptian patients who were confirmed COVID-19-positive based on the polymerase chain reaction (PCR) test. After applying the exclusion criteria, cases with mild-to-moderate symptoms were included in the study. The questionnaire consisted of 4 sections. The 1st section included demographic data, smoking, alcohol consumption, and general health status. The 2nd section contained questions regarding the oral hygiene status of the patients, and additionally a question about the hygienic measures they took while being infected with COVID-19. The 3rd section included questions about the most commonly reported COVID-19 symptoms the patients suffered from. The 4th section included questions that referred to the oral manifestations the patients complained of while being infected with COVID-19. Results. A total of 573 patients were included in this survey. It was reported that 71.7% of COVID-19 patients presented with some oral manifestations at a level of significance, with variable incidence - oral or dental pain (23%), pain in jaw bones or joint (12.0%), halitosis (10.5%), ulcerations (20.4%), and xerostomia (47.6%). Some patients (28.3%) showed 2 or 3 manifestations simultaneously. Conclusions. It was proven that mild-to-moderate cases of COVID-19 infection are associated with oral symptoms, and thus the significance of dental examination of patients with communicable diseases should be emphasized.
引用
收藏
页码:7 / 15
页数:9
相关论文
共 50 条
  • [31] Monoclonal Antibody and Antiviral Therapy for Mild-to-Moderate COVID-19 in Pediatric Patients
    Vora, Surabhi B. B.
    Englund, Janet A. A.
    Trehan, Indi
    Waghmare, Alpana
    Kong, Ada
    Adler, Amanda
    Zerr, Danielle M. M.
    [J]. PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2023, 42 (01) : 32 - 34
  • [32] Integrative medicine considerations for convalescence from mild-to-moderate COVID-19 disease
    Alschuler, Lise
    Chiasson, Ann Marie
    Horwitz, Randy
    Sternberg, Esther
    Crocker, Robert
    Weil, Andrew
    Maizes, Victoria
    [J]. EXPLORE-THE JOURNAL OF SCIENCE AND HEALING, 2022, 18 (02) : 140 - 148
  • [33] Cognitive Impairment in Non-critical, Mild-to-Moderate COVID-19 Survivors
    Henneghan, Ashley M.
    Lewis, Kimberly A.
    Gill, Eliana
    Kesler, Shelli R.
    [J]. FRONTIERS IN PSYCHOLOGY, 2022, 13
  • [34] Considerations for Return to Exercise following Mild-to-Moderate COVID-19 in the Recreational Athlete
    Metzl, Jordan D.
    McElheny, Kathryn
    Robinson, James N.
    Scott, Daphne A.
    Sutton, Karen M.
    Toresdahl, Brett G.
    [J]. HSS JOURNAL, 2020, 16 (1_SUPPL) : 102 - 107
  • [35] The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19
    Arimura, Ken
    Tagaya, Etsuko
    Kikuchi, Ken
    Mitsuda, Toshihiro
    Ebihara, Fumiya
    Maruyama, Takumi
    Hamada, Yukihiro
    Unagami, Kohei
    Kanzawa, Taichi
    Sekiguchi, Haruki
    Shimamoto, Ken
    Ishida, Hideki
    Egawa, Hiroto
    Tanaka, Junji
    Kawana, Masatoshi
    [J]. TRANSPLANT IMMUNOLOGY, 2023, 77
  • [36] Clinical and subclinical acute kidney injury in children with mild-to-moderate COVID-19
    Saygili, Seha
    Canpolat, Nur
    Cicek, Rumeysa Yasemin
    Agbas, Ayse
    Yilmaz, Esra Karabag
    Sakalli, Ayse Ayzit Kilinc
    Aygun, Deniz
    Akkoc, Gulsen
    Demirbas, Kaan Can
    Konukoglu, Dildar
    Cokugras, Haluk
    Caliskan, Salim
    Sever, Lale
    [J]. PEDIATRIC RESEARCH, 2023, 93 (03) : 654 - 660
  • [37] Mild-to-moderate COVID-19 may affect nervous system function in convalescents
    Lulek, M.
    Malecka-Gieldowska, M.
    Ciepiela, O.
    [J]. CLINICA CHIMICA ACTA, 2024, 558 : 2 - 3
  • [38] Clinical Pathways When Considering Antimicrobials for the Treatment of Mild-to-Moderate COVID-19
    Krauth, Daniel S.
    [J]. MILITARY MEDICINE, 2022, 187 (7-8) : 186 - 188
  • [39] Monoclonal antibodies for mild-to-moderate COVID-19 in multiple sclerosis: A case series
    Moccia, Marcello
    Buonomo, Antonio Riccardo
    Scotto, Riccardo
    Viceconte, Giulio
    Nobile, Mariano
    Lanzillo, Roberta
    Morra, Vincenzo Brescia
    Gentile, Ivan
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 439
  • [40] Bamlanivimab use in mild-to-moderate COVID-19 disease: A matched cohort design
    Destache, Christopher J.
    Aurit, Sarah J.
    Schmidt, David
    Erkes, Laura Peet
    Tierney, Maureen
    Vivekanandan, Renuga
    [J]. PHARMACOTHERAPY, 2021, 41 (09): : 743 - 747